MedPath
NMPA Approval

Rivastigmine Bitartrate Oral Solution

国药准字H20244273

June 28, 2024

Drug Information

重酒石酸利斯的明口服溶液

口服溶液剂

120ml:0.24g(按C₁₄H₂₂N₂O₂计)

化学药品

June 28, 2024

Company Information

Applicant Company

吉林省磐石经济开发区西点大街777号

Manufacturing Company

山东省德州市齐河县晏北街道办事处齐众大道127号

© Copyright 2025. All Rights Reserved by MedPath